Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Cohen

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Nature Biotechnology|November 9, 2010
What is the value of oncology medicines?Joshua Cohen, William Looney
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
Patient access to new cancer drugs in the United States and AustraliaAndrew Wilson, Joshua Cohen
American Journal of Therapeutics|January 29, 2008
Follow-on drugs and indications: the importance of incremental innovation to medical practiceJoshua Cohen, Kenneth Kaitin
Mabs|January 5, 2010
New challenges to medicare beneficiary access to mAbsJoshua Cohen, Andrew Wilson
Journal of the National Cancer Institute|July 24, 2010
Re: How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion questionJoshua Cohen, William Looney
The Journal of Medicine and Philosophy|June 20, 2003
On the possibility of a positive-sum game in the distribution of health care resourcesJoshua Cohen, Edwige Burg
Neurobiology of Learning and Memory|March 5, 2011
Extinction of appetitive learning is disrupted by cycloheximide and propranolol in the sand maze in ratsJoshua Cohen, Gretchen Hanson Gotthard
Plastic and Reconstructive Surgery|May 25, 2016
Discussion: Analysis of References on the Plastic Surgery In-Service Training ExamJoshua Cohen, Pierre B Saadeh
Health Affairs (Project Hope)|April 10, 2013
Compared to US practice, evidence-based reviews in Europe appear to lead to lower prices for some drugsJoshua Cohen, Ashley Malins, Zainab Shahpurwala
Plos One|December 25, 2013
Economic impact of a triptan Rx-to-OTC switch in six EU countriesAurelie Millier, Joshua Cohen, Mondher Toumi
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Nature Biotechnology|November 9, 2010
What is the value of oncology medicines?Joshua Cohen, William Looney
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
Patient access to new cancer drugs in the United States and AustraliaAndrew Wilson, Joshua Cohen
American Journal of Therapeutics|January 29, 2008
Follow-on drugs and indications: the importance of incremental innovation to medical practiceJoshua Cohen, Kenneth Kaitin
Mabs|January 5, 2010
New challenges to medicare beneficiary access to mAbsJoshua Cohen, Andrew Wilson
Journal of the National Cancer Institute|July 24, 2010
Re: How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion questionJoshua Cohen, William Looney
The Journal of Medicine and Philosophy|June 20, 2003
On the possibility of a positive-sum game in the distribution of health care resourcesJoshua Cohen, Edwige Burg
Neurobiology of Learning and Memory|March 5, 2011
Extinction of appetitive learning is disrupted by cycloheximide and propranolol in the sand maze in ratsJoshua Cohen, Gretchen Hanson Gotthard
Plastic and Reconstructive Surgery|May 25, 2016
Discussion: Analysis of References on the Plastic Surgery In-Service Training ExamJoshua Cohen, Pierre B Saadeh
Health Affairs (Project Hope)|April 10, 2013
Compared to US practice, evidence-based reviews in Europe appear to lead to lower prices for some drugsJoshua Cohen, Ashley Malins, Zainab Shahpurwala
Plos One|December 25, 2013
Economic impact of a triptan Rx-to-OTC switch in six EU countriesAurelie Millier, Joshua Cohen, Mondher Toumi
Pageof 17